BioHorizons, Inc., a leading innovator in the dental implant and regenerative medicine industry, is headquartered in the United States. Founded in 1994, the company has established itself as a key player in the global market, with a strong presence in North America and Europe. BioHorizons is renowned for its advanced dental implant systems and biologics, which are designed to enhance patient outcomes through superior technology and innovative design. The company’s core offerings include dental implants, surgical instruments, and regenerative solutions, all distinguished by their commitment to quality and innovation. BioHorizons has achieved notable milestones, including numerous patents and awards that underscore its position as a trusted provider in the dental field. With a focus on research and development, BioHorizons continues to lead the way in creating effective solutions for dental professionals worldwide.
How does BioHorizons, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BioHorizons, Inc.'s score of 61 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BioHorizons, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Henry Schein, Inc., and therefore, any climate commitments or emissions data may be inherited from this parent organisation. As part of its climate strategy, BioHorizons aligns with initiatives from Henry Schein, Inc., which includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements have not been disclosed for BioHorizons itself. The absence of direct emissions data suggests that BioHorizons is still in the process of establishing its own climate commitments or may rely on the broader corporate strategies of Henry Schein, Inc. to guide its environmental impact efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
BioHorizons, Inc.'s Scope 3 emissions, which increased by 92% last year and increased significantly since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 74% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BioHorizons, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.